Results 211 to 220 of about 677,185 (349)

Atypical Visually Guided Precision Grip Control in Middle‐Aged and Older Autistic Adults

Autism Research, EarlyView.
ABSTRACT Sensorimotor impairments are well documented in autism spectrum disorder (ASD). However, little is known about how these difficulties present in middle‐aged and older autistic adults or how they relate to demographic factors and autistic traits.
Zheng Wang, Hang Qu, Danielle Christensen, Hanna M. Gemmell, Ellen M. Parks, Kyla E. Wetherington, Ann‐Marie Orlando, Regilda A. Romero, Bikram Karmakar, David E. Vaillancourt   +9 more
wiley   +1 more source

Oral Medicine: a retrospective analysis of patient profiles, diagnoses, and referral patterns in Mexico City. [PDF]

Med Oral Patol Oral Cir Bucal
Figueroa-Ramos AM, Anaya-Saavedra G, Irigoyen-Camacho ME, Mosqueda-Taylor A.   +3 more
europepmc   +1 more source

Pharmacogenomics in clinical practice: Biomarker information in Brazilian drug labels

British Journal of Clinical Pharmacology, EarlyView.
This review examines the PGx annotations in package inserts (bulas in Brazilian Portuguese) approved by ANVISA, the Brazilian Health Regulatory Agency, for 19 gene–drug pairs with strong or moderate recommendations for initial dosing alteration in the CPIC (Clinical Pharmacogenetic Implementation Consortion) guidelines and PGx testing required or ...
Guilherme Suarez‐Kurtz
wiley   +1 more source

Lived experiences of chemotherapy-induced oral mucositis among patients with breast cancer: a phenomenological study. [PDF]

BMJ Open
Ababneh A, Alrida NA, Ababneh A, Eid HM, Tailakh S, Al-Zu'bi B.   +5 more
europepmc   +1 more source

Population pharmacokinetics and exposure–response analysis of durvalumab in patients with resectable stage II to IIIB (N2) NSCLC in the phase III AEGEAN study

British Journal of Clinical Pharmacology, EarlyView.
Aims In the AEGEAN study, perioperative durvalumab plus platinum‐based neoadjuvant chemotherapy for patients with resectable stage II to IIIB (N2) non‐small‐cell lung cancer (NSCLC) demonstrated a favourable benefit–risk profile. This study evaluated population pharmacokinetics (PopPK) and exposure–response (ER) relationships of durvalumab in patients ...
Xiaoying Zhao, Junjie Ding, Jiajia Zhao, Ling Zhang, Aburough Abegesah, Yu‐qian Zhang, Cathy O'Brien, Gary J. Doherty, Allen C. Chen, KyoungSoo Lim, Song Ren, Peiming Ma, Diansong Zhou   +12 more
wiley   +1 more source

A case of "buckshot" metastatic melanoma: A rare and aggressive pattern of cutaneous spread. [PDF]

SAGE Open Med Case Rep
Werpachowski N, Carr C.
europepmc   +1 more source

Methylation-Driven downregulation of GABRB2 in oral carcinoma's subtype: implications for early diagnosis and differentiation. [PDF]

BMC Oral Health
Sen S, Doruk C, Ulusan M, Olgaç V, Ak G, Demokan S.   +5 more
europepmc   +1 more source

Single‐component cationic polyethylenimine thermogel for sustained and localized gene delivery to combat multi‐drug resistant cancer

BMEMat, EarlyView.
A cationic thermogelling copolymer employing branched PEI‐25 kDa as the sole hydrophilic segment can be facilely complexed with plasmid by physical mixing in the sol phase. Spontaneous gelation is achieved via self‐assembly after injection due to physiological temperature. Sustained and localized release of plasmid from the cationic PEI‐thermogel leads
Qianyu Lin, Minting Liu, Lingjie Ke, Nicholas Wei Xun Ong, Joey Hui Min Wong, Cally Owh, Valerie Ow, Belynn Sim, Yi Jian Boo, Jason Y. C. Lim, Yunlong Wu, Xian Jun Loh   +11 more
wiley   +1 more source

Patient-reported outcomes after ipsilateral radiation therapy for N2b tonsillar squamous cell carcinoma. [PDF]

Discov Oncol
Abana CO, Garden AS, Brandon Gunn G, Chronowski GM, Mohamed ASR, Frankart AJ, Geier N, Bahig H, Barbon CEA, Hutcheson K, Takiar V, Fuller CD, Frank SJ, Rosenthal DI, Phan J.   +14 more
europepmc   +1 more source